Roche alleges counterfeit diabetes medical devices were sold on Amazon

Roche alleges counterfeit diabetes medical devices were sold on Amazon

Roche Diabetes Care Inc. Accu-Chek brand glucose test strips are arranged for a photograph in the Brooklyn borough of New York, U.S., on Thursday, April 4, 2019.  Alex Flynn | Bloomberg | Getty Images Roche, one of the world’s largest biotech companies, said “dangerous counterfeits” of its diabetes medical devices ended up for sale on … Read more

Moderna combination Covid, flu vaccine shows positive late-stage data

Moderna combination Covid, flu vaccine shows positive late-stage data

Empty bottles of Moderna’s Covid-19 vaccine. Fred Tanneau | AFP | Getty Images Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.  The biotech company is the first to release positive phase three data on a … Read more

Trump claims credit for Biden’s insulin price cap

Trump claims credit for Biden’s insulin price cap

President Joe Biden and former President Donald Trump 2024. Kevin Lamarque | Jay Paul | Reuters Former President Donald Trump on Saturday recognized that the price of insulin is lower under President Joe Biden, but he still wants voters to credit his own administration. “Low INSULIN PRICING was gotten for millions of Americans by me, and … Read more

FDA approves GSK RSV vaccine for adults 50 to 59

FDA approves GSK RSV vaccine for adults 50 to 59

A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus.  The shot, called Arexvy, … Read more

Alphabet CFO Anat Ashkenazi jumps from GLP-1 boom to generative AI

Alphabet CFO Anat Ashkenazi jumps from GLP-1 boom to generative AI

Alphabet incoming CFO Anat Ashkenazi, who spent 23 years at Eli Lilly Eli Lilly Alphabet’s outgoing finance chief, Ruth Porat, spent the past year and a half trying to help her internet company navigate the generative artificial intelligence boom. The person who was just named her successor was knee-deep in a very different phenomenon: anti-obesity … Read more

GSK plunges after U.S. court makes Zantac ruling

GSK plunges after U.S. court makes Zantac ruling

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020.  Matthew Childs | Reuters LONDON — Shares of British pharmaceuticals giant GSK plunged 9% Monday, after a U.S. court ruled that scientific evidence could be presented as a stack of lawsuits relating to the discontinued heartburn drug Zantac move forward. … Read more

Moderna, Merck cancer vaccine with Keytruda improved survival in trial

Moderna, Merck cancer vaccine with Keytruda improved survival in trial

Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck’s Keytruda improved survival and showed long-lasting efficacy in a midstage study in patients with a deadly form of skin cancer. … Read more

Indian market: Markets optimistic but ‘mistakenly euphoric’, says Kotak Institutional Equities

Indian market: Markets optimistic but ‘mistakenly euphoric’, says Kotak Institutional Equities

Mumbai: Kotak Institutional Equities said the Indian market continues to be a mix of being “rightfully optimistic and mistakenly euphoric”. The brokerage said parts of the market rightfully reflect the strength of the Indian economy and its long-term growth prospects, while the other parts reflect “extreme euphoria linked to baseless narratives.” Kotak said the market … Read more

FDA approves Moderna RSV vaccine for seniors

FDA approves Moderna RSV vaccine for seniors

The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the company’s second-ever product to enter the U.S. market.  The decision is a win for Moderna, which desperately needs another revenue source amid … Read more

Pfizer lung cancer drug shows promising long-term trial results

Pfizer lung cancer drug shows promising long-term trial results

CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment for the condition. The company’s medicine helped patients live longer without seeing their cancer progress, and most people experienced that benefit for … Read more